Korean Market
OTHR
Cell Bio Human Tech
★

Cell Bio Human Tech Completes 5 Billion Won Treasury Stock Acquisition via Trust, Enhancing Shareholder Value

 
OWNR
Cell Bio Human Tech
★

Largest Shareholder Lee Kwon-seon Increases Stake to 37.13%, Strengthening Control via Open Market Purchases and Affiliate Acquisition

 
MATR
Cell Bio Human Tech
★

Cell Bio Human Tech Enters 1 Billion KRW Treasury Stock Acquisition Trust Agreement to Enhance Shareholder Value

 
OTHR
Cell Bio Human Tech
★

Cell Bio Human Tech terminates treasury stock trust, acquires 74,956 shares worth 500 million KRW, representing 0.8% of outstanding shares, minor impact

 
MATR
Cell Bio Human Tech
★

Cell Bio Human Tech Terminates Treasury Stock Acquisition Trust After Acquiring 74,956 Shares… Shareholder Value Enhancement Buyback Completed

 
OWNR
Cell Bio Human Tech
★

CEO Kwon-seon Lee Increases Stake to 34.65% via Open Market Purchases

 
OWNR
Cell Bio Human Tech
★

CEO Kwon-seon Lee acquires additional 7,053 shares via open market purchase (avg. 6,978 won)

 
EXCH
Cell Bio Human Tech
★

Correction Announcement for Acquisition of Tangible Assets - Factory Purchase of 5.4 Billion KRW, Date Change

 
PERI
Cell Bio Human Tech
★★

Cell Bio Human Tech Q1 2026 Consolidated Revenue 12.7B KRW… Up 54% YoY

 
EXCH
Cell Bio Human Tech
★

Completion of Small Capital Reduction, 3,688 Shares Reduced